Insulin tolerance tests or clamp studies were not done to evaluate the effect of baricitinib on insulin sensitivity, but proxy measures showed a trend toward improved insulin action after the 4-week treatment (fig.
← all excerpts
Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches.
1
—
—